A lot of Amgen’s future rides on its experimental obesity medicine MariTide. At least in the minds of investors.
Ahead of the biopharma’s most critical …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Coming off some recent setbacks, Immatics is rolling out its latest update on a new approach to solid tumors that’s bolstered hopes and inspired a
The first over-the-counter glucose sensors will launch in the U.S. this summer. Dexcom and Abbott received Food and Drug Administration clearance for OTC continuous glucose